emat

Buy Complete Report

Prix: €120 HT

Logo CreditCards Visa Logo CreditCards Mastercard

This report is accessible on EMAT, the reference database for private company acquisition multiples

 

 

► Subscribe to EMAT database

 

Sectors covered by our analysts

 

► Studies & indices published by Epsilon Research: Register to receive (free) publications updates

 

► Alert on reports published: Sign up (free) to receive by e-mail updates on EMAT reports published on your preferred sector.

 

Transaction Multiples for the Valuation of Private Companies

BICO Group (formerly CELLINK) / QInstruments

No EMAT : 106707
Announced Date : 01/10/2021
Type : Acquisition of Majority Stake
Deal Value : Yes
Acquirer : BICO Group (formerly CELLINK)

Target : QInstruments
Country : Germany
Sector of activity :
  • Health Care Providers, Medical Equipment and Supplies > Health, Pharmaceuticals & Biotechnology > Medical Equipment
Business Description :
Founded in 2003, by , QInstruments develops, manufactures and supplies advanced sample preparation automation by mixing solutions for liquid handling robots and workflows for biomedical and life...

Transaction multiples available
EV/
Sales
EV/
Gross Profit
EV/
EBITDA
EV/
EBIT
Eq/
PBT
P/E Price
to Book
Specific
multiple(s)
Historic ns
Current
Rating : **
Multiple available
n.s.   Multiple calculated, but not significant

Source: Epsilon Research / EMAT

Comparable Transactions

  • Number of EMAT Reports / sub-sector « Medical Equipment » = 225
Example of comparable transactions on EMAT (same sub-sector):
Date Acquirer Target Country Multiples See details
25/09/2021 Private group led by Siparex Destia Loiret ** 106691
15/07/2021 Private Group led by Ares Management and Bpifrance Point Vision France * 106658

Source: Epsilon Research / EMAT

About Epsilon Research

Epsilon Research is an independent research and financial analysis bureau, and the reference source of transaction multiples for the valuation of private companies through its EMAT database.

EMAT Report

► Each EMAT Report includes the detailed analysis of the transaction: deal rationale and structure, target business lines and financials (restated), valuation multiples (calculation and analysis).

 

► Example of EMAT Report